These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 23750335)

  • 1. Cardiovascular Disease Risk Assessment: Insights from Framingham.
    D'Agostino RB; Pencina MJ; Massaro JM; Coady S
    Glob Heart; 2013 Mar; 8(1):11-23. PubMed ID: 23750335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular risk estimation in 2012: lessons learned and applicability to the HIV population.
    D'Agostino RB
    J Infect Dis; 2012 Jun; 205 Suppl 3(Suppl 3):S362-7. PubMed ID: 22577209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. General cardiovascular risk profile for use in primary care: the Framingham Heart Study.
    D'Agostino RB; Vasan RS; Pencina MJ; Wolf PA; Cobain M; Massaro JM; Kannel WB
    Circulation; 2008 Feb; 117(6):743-53. PubMed ID: 18212285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with Type 2 diabetes mellitus.
    Metcalf PA; Wells S; Scragg RK; Jackson R
    N Z Med J; 2008 Sep; 121(1281):49-57. PubMed ID: 18797484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lifetime risk and years lived free of total cardiovascular disease.
    Wilkins JT; Ning H; Berry J; Zhao L; Dyer AR; Lloyd-Jones DM
    JAMA; 2012 Nov; 308(17):1795-801. PubMed ID: 23117780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of serum lipid level change on 10-year coronary heart risk distribution estimated by means of seven different coronary risk scores during one-year treatment.
    Kojić NE; Derić M; Dejanović J
    Med Pregl; 2014; 67(7-8):208-15. PubMed ID: 25151760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fixed-dose combination therapy for the prevention of cardiovascular disease.
    de Cates AN; Farr MR; Wright N; Jarvis MC; Rees K; Ebrahim S; Huffman MD
    Cochrane Database Syst Rev; 2014 Apr; 4(4):CD009868. PubMed ID: 24737108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex-specific differences in the predictive value of cholesterol homeostasis markers and 10-year cardiovascular disease event rate in Framingham Offspring Study participants.
    Matthan NR; Zhu L; Pencina M; D'Agostino RB; Schaefer EJ; Lichtenstein AH
    J Am Heart Assoc; 2013 Feb; 2(1):e005066. PubMed ID: 23525441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting the 30-year risk of cardiovascular disease: the framingham heart study.
    Pencina MJ; D'Agostino RB; Larson MG; Massaro JM; Vasan RS
    Circulation; 2009 Jun; 119(24):3078-84. PubMed ID: 19506114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of Framingham cardiovascular disease (CVD) predictions in the Rotterdam Study taking into account competing risks and disentangling CVD into coronary heart disease (CHD) and stroke.
    van Kempen BJ; Ferket BS; Kavousi M; Leening MJ; Steyerberg EW; Ikram MA; Witteman JC; Hofman A; Franco OH; Hunink MG
    Int J Cardiol; 2014 Feb; 171(3):413-8. PubMed ID: 24438922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertension and cardiovascular disease: contributions of the framingham heart study.
    Franklin SS; Wong ND
    Glob Heart; 2013 Mar; 8(1):49-57. PubMed ID: 25690263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of Treatment Effects for Intensive Blood Pressure Therapy by Individual Components of FRS: An Unsupervised Data-Driven Subgroup Analysis in SPRINT and ACCORD.
    Wu Y; Bai J; Zhang M; Shao F; Yi H; You D; Zhao Y
    Front Cardiovasc Med; 2022; 9():778756. PubMed ID: 35187120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of a Framingham cardiovascular risk model among Indians and Europeans in New Zealand and the role of body mass index and social deprivation.
    Rabanal KS; Meyer HE; Pylypchuk R; Mehta S; Selmer RM; Jackson RT
    Open Heart; 2018; 5(2):e000821. PubMed ID: 30018780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study.
    Hippisley-Cox J; Coupland C; Vinogradova Y; Robson J; May M; Brindle P
    BMJ; 2007 Jul; 335(7611):136. PubMed ID: 17615182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
    Whitfield MD; Gillett M; Holmes M; Ogden E
    Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of cardiovascular disease and its associated risk factors in at-risk men and women in the United Arab Emirates: a 9-year retrospective cohort study.
    Al-Shamsi S; Regmi D; Govender RD
    BMC Cardiovasc Disord; 2019 Jun; 19(1):148. PubMed ID: 31208354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concept and usefulness of cardiovascular risk profiles.
    Kannel WB; D'Agostino RB; Sullivan L; Wilson PW
    Am Heart J; 2004 Jul; 148(1):16-26. PubMed ID: 15215787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular disease prevalence and insulin resistance in the Kyushu-Okinawa Population Study and the Framingham Offspring Study.
    Ikezaki H; Ai M; Schaefer EJ; Otokozawa S; Asztalos BF; Nakajima K; Zhou Y; Liu CT; Jacques PF; Cupples LA; Furusyo N
    J Clin Lipidol; 2017; 11(2):348-356. PubMed ID: 28502490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Validation of Risk Prediction Models for Cardiovascular Events in Black Adults: The Jackson Heart Study Cohort.
    Fox ER; Samdarshi TE; Musani SK; Pencina MJ; Sung JH; Bertoni AG; Xanthakis V; Balfour PC; Shreenivas SS; Covington C; Liebson PR; Sarpong DF; Butler KR; Mosley TH; Rosamond WD; Folsom AR; Herrington DM; Vasan RS; Taylor HA
    JAMA Cardiol; 2016 Apr; 1(1):15-25. PubMed ID: 27437649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved Framingham Risk Scores of Patients with Type 2 Diabetes Mellitus in the Beijing Community: A 10-Year Prospective Study of the Effects of Multifactorial Interventions on Cardiovascular Risk Factors (The Beijing Communities Diabetes Study 22).
    Zhang XL; Wan G; Yuan MX; Yang GR; Fu HJ; Zhu LX; Xie RR; Lv YJ; Zhang JD; Li YL; Dai QF; Ji Y; Holman RR; Yuan SY;
    Diabetes Ther; 2020 Apr; 11(4):885-903. PubMed ID: 32086768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.